Guardant Health Inc (NAS:GH)
$ 23.52 -0.08 (-0.34%) Market Cap: 2.89 Bil Enterprise Value: 3.21 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 69/100

Guardant Health Inc at SVB Leerink Global Healthcare Conference (Virtual) Transcript

Feb 26, 2021 / 09:20PM GMT
Release Date Price: $147.18 (-1.52%)
Puneet Souda
SVB Leerink LLC, Research Division - MD of Life Science Tools & Diagnostics and Senior Research Analyst

All right. Great. Welcome, everyone. I'm Puneet Souda, SVB Leerink tools and diagnostic analyst. And it's my pleasure to be hosting Guardant Health at our conference. We're literally saving the best for last here.

And so first of all, Helmy Eltoukhy, CEO at Guardant; and Michael Bell, CFO. Glad to have you guys. Welcome to our conference.

Helmy Eltoukhy
Guardant Health, Inc. - Co-Founder, CEO & Director

Thank you for having us.

Questions & Answers

Puneet Souda
SVB Leerink LLC, Research Division - MD of Life Science Tools & Diagnostics and Senior Research Analyst

Great. So to me, Guardant Health is really the best-in-class liquid biopsy company that is expanding into a massive TAM of more than $50 billion. And as products across that continuum from late-stage to upcoming trial readout, positioning the company into screening markets as well. So a lot to talk about,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot